Honoring SMA Awareness Month
Each August, Spinal Muscular Atrophy (SMA) Awareness Month offers an opportunity to reflect on the progress made in diagnosing and treating this rare neuromuscular disorder. As healthcare professionals, we play a critical role in advancing care, which is why we’re highlighting current clinical insights, evolving treatment paradigms, and the latest research that’s shaping the future of SMA management.
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
NeuroFrontiersASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
NeuroFrontiersSafety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
NeuroFrontiersNew-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
Charles Turck, PharmD, BCPS, BCCCP
John Brandsema, MD
Closing Care Gaps and Addressing Unmet Needs in SMA
NeuroFrontiersClosing Care Gaps and Addressing Unmet Needs in SMA
Jennifer Kwon, MD
Examining Care Collaborations for Patients with SMA
NeuroFrontiersExamining Care Collaborations for Patients with SMA
Andrew Wilner, MD, FACP, FAAN
Nassim Rad, MD
Vanessa Battista, RN
- advertisement
- 08/18/2025
- 08/06/2025
- 08/04/2025
- 02/24/2025